Dihydroartemisinin-Piperaquine (DP) for malaria

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 22 Jun 2022: Trial registered, NCT05426434
  2. 31 Aug 2022: Trial started, NCT05426434

The trials

NCT05426434: Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment in Pregnancy

State
Under way
Phase
Phase 3
People
1,172 planned
Started
31 Aug 2022
Primary completion
31 Mar 2025
Arms
SP + DP given every 4 weeks
Results
None posted
  1. 22 Jun 2022: Trial registered
  2. 31 Aug 2022: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.